已收盤 09-20 16:00:00 美东时间
0.000
0.00%
Akebia Therapeutics and U.S. Renal Care Initiate the Voice Trial of Vafseo® (Va...
09-05 20:00
Akebia Therapeutics Inc Files for Mixed Shelf of up to $250 Mln - SEC Filing
09-04 04:08
CSL press release (OTCQX:CSLLY): FY NPATA EPS of $6.02. Revenue of $14.8B (+11.2% Y/Y) misses by $910M. More on CSL CSL Limited (CSLLY) Q4 2024 Earnings Call Transcript Akebia regains full rights to ...
08-14 01:54
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-12 19:00
Akebia Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $7.5 From $6
08-12 18:12
8月8日晚间,中国工商银行发布公告称,国家金融监督管理总局已核准莫里·洪恩先生担任工行独立董事的任职资格。 这意味着,“宇宙行”董事会里又正式入列了一位“洋外脑...
08-09 06:40
Akebia press release (NASDAQ:AKBA): Q2 GAAP EPS of -$0.04. Revenue of $43.67M (-22.5% Y/Y). More on Akebia Akebia regains full rights to kidney disease therapy from CSL Seeking Alpha’s Quant Rating on...
08-08 19:57
Akebia Therapeutics Q2 Operating Expenses USD 35.326 Million
08-08 19:00
Akebia Therapeutics Q2 Net Income USD -8.582 Million
08-08 19:00
CAMBRIDGE, Mass., July 29, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disea...
07-29 20:00